orchid pharma under pressure. revenue & margin decline on qoq basis | cnbc tv18
Published 3 months ago • 404 plays • Length 1:09
Download video MP4
Download video MP3
Similar videos
-
0:59
stocks in news | what are the key stocks in focus today? | august 27, 2024 | n18s | cnbc tv18
-
7:17
cdmo business has been seeing margin of 14-15%: akums drugs & pharma | cnbc tv18
-
8:36
dcgi has asked for phase 4 clinical trials for enmetazobactam drug: orchid pharma | cnbc tv18
-
2:00
zydus under pressure after teva gets us fda approval for asacol hd generic | cnbc tv18
-
0:41
is now a good time to invest in gold etfs? | n18s | cnbc tv18
-
5:00
orchid pharma partners with cipla for antibiotic cefepime-enmetazobactam, launch likely in august
-
2:15
moneycontrol pro ideas for profit: medi assist | cnbc tv18
-
9:44
aim for $15-20 m in terms of sales in the us in the next 3-5 years: poly medicure | cnbc tv18
-
1:47
medi assist, tata elxsi, tata tech, abb india gain while titan, minda corp, syngene slump in trade
-
13:16
valuations are worryingly high for some segments of the market: vetri subramaniam of uti asset mgmt
-
2:01
orchid pharma antibiotic 'exblifeb' gets approval from european medicines agency | cnbc tv18
-
6:48
the significance of ai is still underappreciated by the markets, says deepwater's gene munster
-
14:39
amit jaiswal of royal orchid hotels on earnings, new hotels, growth and more
-
24:48
premier energies ipo: solar powerhouse worth your investment?
-
6:44
co growing at 15-20% per annum & hope to continue growth momentum for next 3-4 yrs: orchid pharma
-
16:44
moving from momentum to quality & from low-float to high-float stocks: kotak mahindra amc
-
20:45
your stock | future of orchid pharma, rel comm, inox leisure & more | cnbc tv18
-
8:16
₹1,000 cr of the fresh issue will be utilised for greenfield expansion: premier energies | cnbc tv18
-
1:24
nuvama initiates coverage of royal orchid, with 'buy' rating | chartbusters | cnbc-tv18
-
8:11
not holding any pharma names, focused on chemicals: icici securities pms | cnbc tv18
-
1:11
emcure pharma gains after jefferies initiates coverage with buy rating & target price of ₹1,600
-
24:52
bulls reclaim some lost ground; heat on maiden pharma; russia-ukraine war | india business hour
Clip.africa.com - Privacy-policy